BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17612819)

  • 1. Illicit use of opioids: is OxyContin a "gateway drug"?
    Grau LE; Dasgupta N; Harvey AP; Irwin K; Givens A; Kinzly ML; Heimer R
    Am J Addict; 2007; 16(3):166-73. PubMed ID: 17612819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Every 'never' I ever said came true": transitions from opioid pills to heroin injecting.
    Mars SG; Bourgois P; Karandinos G; Montero F; Ciccarone D
    Int J Drug Policy; 2014 Mar; 25(2):257-66. PubMed ID: 24238956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
    Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
    Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of nonmedical use of OxyContin and other prescription opioid pain relievers before and after the introduction of OxyContin with abuse deterrent properties.
    Cheng HG; Coplan PM
    Postgrad Med; 2018 Aug; 130(6):568-574. PubMed ID: 29978755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications.
    Firestone M; Goldman B; Fischer B
    Int J Drug Policy; 2009 Jan; 20(1):90-2. PubMed ID: 18508256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From oxycodone to heroin: two cases of transitioning opioid use in young Australians.
    Dertadian GC; Maher L
    Drug Alcohol Rev; 2014 Jan; 33(1):102-4. PubMed ID: 24256365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis.
    Young AM; Havens JR
    Addiction; 2012 Mar; 107(3):587-96. PubMed ID: 21883604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.
    Hakansson A; Medvedeo A; Andersson M; Berglund M
    Eur Addict Res; 2007; 13(4):207-15. PubMed ID: 17851242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.
    Jones CM
    Drug Alcohol Depend; 2013 Sep; 132(1-2):95-100. PubMed ID: 23410617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
    Cicero TJ; Inciardi JA; Muñoz A
    J Pain; 2005 Oct; 6(10):662-72. PubMed ID: 16202959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the Nonmedical Use of OxyContin, United States, 2006 to 2013.
    Jones CM; Muhuri PK; Lurie PG
    Clin J Pain; 2017 May; 33(5):452-461. PubMed ID: 27513641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic pain, addiction severity, and misuse of opioids in Cumberland County, Maine.
    Heimer R; Dasgupta N; Irwin KS; Kinzly M; Harvey AP; Givens A; Grau LE
    Addict Behav; 2012 Mar; 37(3):346-9. PubMed ID: 22138379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Wu LT; Woody GE; Yang C; Blazer DG
    J Addict Med; 2011 Mar; 5(1):28-35. PubMed ID: 21532972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population.
    Martins SS; Storr CL; Zhu H; Chilcoat HD
    Drug Alcohol Depend; 2009 Jan; 99(1-3):58-67. PubMed ID: 18706774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-medical use of OxyContin Tablets in the United States.
    Sees KL; Di Marino ME; Ruediger NK; Sweeney CT; Shiffman S
    J Pain Palliat Care Pharmacother; 2005; 19(2):13-23. PubMed ID: 16061457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
    Cicero TJ; Ellis MS
    JAMA Psychiatry; 2015 May; 72(5):424-30. PubMed ID: 25760692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone.
    Peacock A; Degenhardt L; Larance B; Cama E; Lintzeris N; Ali R; Bruno R
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1321-33. PubMed ID: 26419615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids.
    Peacock A; Bruno R; Cama E; Kihas I; Larance B; Lintzeris N; Hordern A; White N; Ali R; Degenhardt L
    Drug Alcohol Rev; 2015 Nov; 34(6):611-22. PubMed ID: 26084592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of, and Factors Associated With, Illicit Pharmaceutical Opioid Analgesic Use in a Prospective Cohort of People Who Inject Drugs in Melbourne, Australia.
    Horyniak D; Agius PA; Degenhardt L; Reddel S; Higgs P; Aitken C; Stoové M; Dietze P
    Subst Use Misuse; 2015; 50(13):1650-9. PubMed ID: 26576630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internet-based survey of nonmedical prescription opioid use in the United States.
    Katz N; Fernandez K; Chang A; Benoit C; Butler SF
    Clin J Pain; 2008; 24(6):528-35. PubMed ID: 18574362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.